• Elephas Biosciences signed an exclusive commercial partnership in India with Neuberg Diagnostics to expand access to its elive platform.
• Neuberg plans to integrate the platform into its labs, targeting a launch of its own clinical test in India by end-2026.
• Deal also adds a research collaboration, with Neuberg processing tumor biopsy samples on the platform at its flagship Ahmedabad laboratory.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elephas Biosciences Corp. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.